NRX Pharmaceuticals, Inc.
For the period ended Oct 30, 2026. Filed Nov 2, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 30, 2026 · Filed Nov 2, 2026
Use the contents to explore the available documents and sections.
NRXP$2.38+4.8%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Brian Korb
Brian Korb
Managing Partner, astr partners
(917) 653-5122
brian.korb@astrpartners.com
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.